SH3GL1
Endophilin-A2
Also known as: CNSA1, EEN, MGC111371, SH3D2B, SH3G1_HUMAN, SH3P8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99961
- Gene
- SH3GL1
- Ensembl
- ENSG00000141985
- Chromosome
- 19
- Canonical length
- 368 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the endophilin family of Src homology 3 domain-containing proteins. The encoded protein is involved in endocytosis and may also play a role in the cell cycle. Overexpression of this gene may play a role in leukemogenesis, and the encoded protein has been implicated in acute myeloid leukemia as a fusion partner of the myeloid-lymphoid leukemia protein. Pseudogenes of this gene are located on the long arm of chromosomes 11 and 17. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
368 residues, UniProt reviewed canonical sequence.
>Q99961|SH3GL1
1 MSVAGLKKQF YKASQLVSEK VGGAEGTKLD DDFKEMEKKV DVTSKAVTEV LARTIEYLQP
61 NPASRAKLTM LNTVSKIRGQ VKNPGYPQSE GLLGECMIRH GKELGGESNF GDALLDAGES
121 MKRLAEVKDS LDIEVKQNFI DPLQNLCEKD LKEIQHHLKK LEGRRLDFDY KKKRQGKIPD
181 EELRQALEKF EESKEVAETS MHNLLETDIE QVSQLSALVD AQLDYHRQAV QILDELAEKL
241 KRRMREASSR PKREYKPKPR EPFDLGEPEQ SNGGFPCTTA PKIAASSSFR SSDKPIRTPS
301 RSMPPLDQPS CKALYDFEPE NDGELGFHEG DVITLTNQID ENWYEGMLDG QSGFFPLSYV
361 EVLVPLPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH3GL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 173 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 173 nTPM
- skin: 114 nTPM
- vagina: 88 nTPM
- cervix: 77 nTPM
- adrenal gland: 63 nTPM
- adipose tissue: 58 nTPM
Single-cell type
- esophageal apical cells: 1,038 nCPM
- neutrophils: 229 nCPM
- extravillous trophoblasts: 212 nCPM
- esophageal suprabasal cells: 176 nCPM
- suprabasal keratinocytes: 160 nCPM
- migrating cytotrophoblasts: 117 nCPM
Immune cell
- neutrophil: 5.6 nTPM
- T-reg: 4.1 nTPM
- memory CD4 T-cell: 4 nTPM
- memory CD8 T-cell: 3.9 nTPM
- plasmacytoid DC: 3.8 nTPM
- memory B-cell: 3.6 nTPM
Brain region
- hippocampal formation: 72 nTPM
- cerebral cortex: 71 nTPM
- cerebellum: 68 nTPM
- white matter: 57 nTPM
- medulla oblongata: 53 nTPM
- amygdala: 52 nTPM
ReferencesPubMed · IEDB
Publications for SH3GL1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.
2012 · J Exp Clin Cancer Res · RCR 0.8 · 30 citations - Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer.
2024 · Clin Chim Acta · RCR 0.4 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SH3GL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH3GL1 as an antibody target. Whether an autoantibody or antibody against SH3GL1 could matter depends on whether native SH3GL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH3GL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SH3GL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...